Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1988
08/11/1988WO1988005820A1 Recombinant alveolar surfactant protein
08/11/1988WO1988005789A1 Isolation of single chain proteins with fsh suppressing activity from follicular fluid
08/11/1988WO1988005788A1 Tranforming growth factor-beta
08/11/1988WO1988005787A1 Transforming growth factor-beta
08/11/1988WO1988005786A1 Colony stimulating factors having reduced levels of carbohydrate
08/11/1988WO1988005784A1 Lymphocyte inhibition by hla peptides
08/11/1988WO1988005783A1 Immunosuppressive peptides and methods of use
08/11/1988WO1988005663A1 Pharmaceutical preparation for treating cardiac insufficiency
08/11/1988WO1988005662A1 A process for treating infertility and an agent for use in the process
08/11/1988WO1988005661A1 Vasopressin-based pharmaceutical compositions
08/11/1988WO1988005659A1 Human proteins having anticoagulant and anti-inflammatory activity
08/11/1988WO1988004666A3 Lung cytotoxic peptides
08/11/1988WO1988004664A3 Renin-inhibitory peptides having an epoxide or glycol moiety
08/11/1988WO1988003807A3 Production and use of a novel t-cell suppressor factor
08/11/1988WO1988002374A3 Renin inhibitory peptides having novel c-terminal moieties
08/11/1988DE3703159A1 Cyclic peptides with cytoprotective action
08/11/1988DE3702567A1 Factor producing eosinophils
08/10/1988EP0277895A1 Galenical forms of antiinflammatory gammaglobulins for sublingual administration
08/10/1988EP0277868A2 Dialysis solution and utilisation of peptides based on glycin for its preparation
08/10/1988EP0277829A2 Nonapeptide and decapeptide analogs of LHRH as LHRH antagonists
08/10/1988EP0277751A2 Modified fibrinolytic enzyme
08/10/1988EP0277626A2 Synthetic GHRH analogs
08/10/1988EP0277462A1 Process for the preparation of nasal solutions containing synthetic human calciton.
08/10/1988EP0277437A1 Hepatitis NANB viral agent, antigen and immunological reagent
08/10/1988EP0277419A2 Therapeutic somatostatin analogues
08/10/1988EP0277313A1 Hybrid plasminogen activators
08/10/1988EP0277289A1 Extra pure semi-synthetic blood substitute
08/10/1988EP0277160A1 Immuno-suppressor and process for its manufacture
08/10/1988EP0135532B1 Method of producing and selectively isolating proteins and polypeptides, recombinant and expression vector therefor and fusion protein able to bind to the constant region of immunoglobulins
08/09/1988US4762923 Gastrointestinal, cns, analgesic, antibiotic
08/09/1988US4762913 Antigenic modification of polypeptides
08/09/1988US4762885 Neocarzinostatin derivatives and a process for manufacturing the same
08/09/1988US4762825 Polysaccharide RON substance
08/09/1988US4762824 Compositions and methods useful for uropathogenic bacterial identification or diagnosis and inhibition of adherence of uropathogenic bacteria to cells having a structural element similar to that of the active principle of the invention
08/09/1988US4762821 Hypotensives
08/09/1988US4762820 Therapeutic treatment for congestive heart failure
08/09/1988US4762791 Human immune interferon
08/09/1988US4762784 Fermemtation process for the high level production of bovine growth hormone
08/09/1988US4762717 Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
08/09/1988US4762714 Cold ethanol and storage
08/09/1988US4762707 Medical diagnosis
08/09/1988US4762706 Peptide antibodies and their use in detecting oncogene products
08/09/1988US4762705 Cancer therapy with interferon
08/09/1988CA1240315A1 Neocarzinostatin derivatives and method of producing the same
08/03/1988EP0277096A2 Improved thrombin preparations
08/03/1988EP0277071A2 Process for the production of a human monoclonal antibody (IgG) anti-cytomegalovirus, and monoclonal antibody so obtained
08/03/1988EP0277043A2 Method for recovering somatotropins from dilute aqueous solution
08/03/1988EP0276846A2 Colony-stimulating factor derivatives
08/03/1988EP0276740A1 N15-alkyl and N15,N15-dialkyl derivates of teicoplanin compounds
08/03/1988EP0276591A2 Vaccine consisting of a viral vector and recombinant DNA coding for the p25 protein of the AIDS virus
08/03/1988EP0276551A1 Colony-stimulating factor and method for preparation thereof
08/03/1988EP0276436A1 Phosphinic acid derivatives
08/03/1988EP0276328A1 Process for separating Single-Strand Human tPA and Double-Strand Human tPA from each other
08/03/1988CN86106574A Human insulin analogues
08/02/1988US4761483 Chloro-substituted ketone imidazole derivatives
08/02/1988US4761471 Induce bone formation in animals
08/02/1988US4761469 Isolation, purification and sequence determination of cardionatrins
08/02/1988US4761399 Increase concentration of glutathione in cells and organs
08/02/1988US4761398 Administering a luteinizing hormone releasing hormone receptor ligand
08/02/1988US4761371 Genetic engineering
08/02/1988US4761289 Sustained release implant and method for preparing same
08/02/1988CA1239872A1 Tissue protein pp in19' xxa process for obtaining it, and its use
08/02/1988CA1239871A1 Homogeneous human interleukin 2 and process thereof
07/1988
07/29/1988EP0209539A4 Homogeneous erythropoietin.
07/28/1988WO1988005471A1 Cytotoxic lymphocyte-specific protease-related molecules and methods
07/28/1988WO1988005469A1 Human interleukin-3 proteins
07/28/1988WO1988005440A1 Peptides having immunological properties 2-hiv-2
07/28/1988WO1988005309A1 Potentiation of cytotoxic conjugates
07/28/1988WO1988005306A1 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
07/28/1988WO1988005297A1 Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states
07/28/1988WO1988003173A3 New forms of colony stimulating factor-1
07/28/1988WO1988003151A3 Thrombin derived polypeptides; compositions and methods for use
07/28/1988DE3742473A1 Hydrosols of pharmacological agents and pharmaceutical compositions thereof
07/27/1988EP0276166A2 Composition and method for producing superovulation in cattle
07/27/1988EP0276121A2 Wavelength-specific cytotoxic agents
07/27/1988EP0276120A2 Treatment of certain leukemias with a combination of gamma interferon and alpha interferon
07/27/1988EP0276101A2 Substituted peptide derivatives
07/27/1988EP0276014A2 Anticoagulant peptides
07/27/1988EP0275856A1 New plasminogen activators
07/27/1988EP0275748A1 Peptide derivatives and their therapeutical use
07/27/1988EP0275606A1 Hybrid plasminogen activators with improved thrombolytic properties and drugs comprising these plasminogen activators
07/27/1988EP0275598A1 Molecular cloning and expression of human IL-3
07/27/1988EP0275457A2 Solution containing lysozyme hydrochloride and dipotassium glycyrrhizinate
07/27/1988EP0275404A1 LHRH analog formulations
07/27/1988EP0275305A1 Dna sequences coding for modified factor viii:c and modified factor viii:c-like polypeptides and processes for producing these polypeptides in high yields
07/27/1988EP0275282A1 Process for purifying a plasminogen activator
07/27/1988EP0135182B1 Process for the production of n-alkylated dipeptides and of their esters
07/26/1988US4760180 N-terminally substituted dipeptide amides
07/26/1988US4760131 Wound-healing composition
07/26/1988US4760130 Serine protease inhibitors and methods for isolation of same
07/26/1988US4760053 Administering antiandrogen and/or antiestrogen
07/26/1988US4760052 1,6-dicarba-vasopressin compounds
07/26/1988US4760051 Use of GHL-Cu as a wound-healing and anti-inflammatory agent
07/26/1988US4760023 Complimentary strand of polydeoxyribonucleotide
07/26/1988US4760021 Biological response modifier having cell differentiation-induction activity and process for production thereof
07/26/1988CA1239636A1 Glucosamine-peptide derivatives, their production and use
07/26/1988CA1239606A1 Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
07/26/1988CA1239586A Dialysis solution containing amino acids
07/26/1988CA1239584A1 Method for making gamma globulin-containing compositions
07/26/1988CA1239583A1 Method of inactivating reproducible filterable pathogens in blood products as well as a method of producing blood products